Month: August 2022

OMNIQ Reports Record 6 months results. $50M in revenue for 6 months ended June 30, 2022. Second Quarter $24.2M Revenue up 85% over Q2 2021.

Written by Customer Service on August 15, 2022. Posted in Public Companies.

SALT LAKE CITY, Aug. 15, 2022 (GLOBE NEWSWIRE) — OMNIQ Corp. (NASDAQ: OMQS) (“OMNIQ” or “the Company”), a provider of Supply Chain and Artificial Intelligence (AI)-based solutions, today announced its financial results for the three months and six months ended June 30 , 2022. OMNIQ’s 2022 continuous momentum:54% growth in 6 month Revenue marks an all-time record of over $50 Million. 104% growth in 6 Month Gross Profit up to a record of over $12M. 85% Growth in Q2 Revenue compared to Q2 2021. 81% increase in Q2 Gross Profit compared to Q2 2021. Gross margin for the 6 months up to 24% compared to 18% in the same period of 2021. Q2 marks a breakthrough in penetrating the retail and restaurant markets with the Company’s AI integrated solution. OMNIQ’s Q Shield AI based law enforcement solution offered to municipalities is experiencing positive...

NeoGames’ BtoBet Agrees to Multi-Channel Sportsbook Partnership with SOJOGO, the Lottery Operator in Mozambique

Written by Customer Service on August 15, 2022. Posted in Public Companies.

Will be providing SOJOGO, the Santa Casa da Misericórdia de Lisboa, ELAM and other 9 Mozambican Associations partnership with its proprietary sportsbook solution LUXEMBOURG, Aug. 15, 2022 (GLOBE NEWSWIRE) — NeoGames S.A. (Nasdaq: NGMS) subsidiary BtoBet, a leading sports betting supplier, has announced a multi-year partnership agreement with SOJOGO and Santa Casa Global, the global arm of the Portuguese National Lottery Santa Casa da Misericórdia de Lisboa. Through this partnership BtoBet will be providing SOJOGO with its proprietary sportsbook offering for both its online operations and retail network. Alcinda Santiago, General Director of SOJOGO, said: “In BtoBet we have found a sportsbook platform partner that matches our own ambitions and focus on gaining a leadership role in its market. Francisco Pessoa e Costa, Executive...

Rigetti Computing Announces Upcoming Investor Conference Schedule

Written by Customer Service on August 15, 2022. Posted in Public Companies.

BERKELEY, Calif., Aug. 15, 2022 (GLOBE NEWSWIRE) — Rigetti Computing, Inc. (“Rigetti” or the “Company”) (Nasdaq: RGTI), a pioneer in full-stack quantum-classical computing, today announced its investor conference schedule for August and September 2022. During the period, management will take one-on-one meetings at the Needham & Co. Semiconductor, Jefferies Semiconductor, and Deutsche Bank Technology investor conferences. Chad Rigetti, founder and CEO, also will participate in a fireside chat at the Deutsche Bank Technology conference. Further information regarding these events is included below. 3rd Annual Needham Virtual Semiconductor and SemiCap 1×1 ConferenceChad Rigetti, founder and CEO Wednesday, August 24, 2022, to Thursday, August 25, 2022Jefferies Semis, IT Hardware & Comm Infrastructure...

SciSparc Signs a Non- Binding Letter of Intent to Acquire American Food Supplements and Cosmetics Brand in Approximately $20 Million Deal

Written by Customer Service on August 15, 2022. Posted in Mergers And Acquisitions.

The Letter of Intent contemplates the purchasing of a brand, trademark and Amazon.com seller account, a management agreement, a U.S. distribution agreement and an option to expand to new territories TEL AVIV, Israel, Aug. 15, 2022 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced that it has signed a non-binding letter of intent (“LOI”) with Merhavit M.R.M Holding and Management Ltd (“M.R.M”), to acquire from it its rights to purchase, a top-seller Amazon.com account and American food supplements and cosmetics brand and trademark (the “Brand”). The Brand offers dozens of GMP (Good Manufacturing Practice) manufactured hemp-based, U.S. made, top-ranked...

Vaccinex Reports Second Quarter 2022 Results and Provides Corporate Update; Excellent Progress in Pepinemab Clinical Programs

Written by Customer Service on August 15, 2022. Posted in Earnings Releases And Operating Results.

Promising initial responses in continuing Phase 1b/2 KEYNOTE B84 study of pepinemab with KEYTRUDA® in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Phase 2 SIGNAL-HD Study Published in Nature Medicine Patient enrollment continues in the Phase 1/2a SIGNAL-AD Alzheimer’s study ROCHESTER, N.Y., Aug. 15, 2022 (GLOBE NEWSWIRE) — Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and neurodegenerative disease through the inhibition of SEMA4D, today announced financial results for the second quarter ended June 30, 2022 and provided a corporate update on key events since April, 2022 (the last 5 months). “Vaccinex has made excellent progress this year in its clinical programs to evaluate the potential use of our proprietary SEMA4D inhibitor, pepinemab,...

AIM ImmunoTech Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Written by Customer Service on August 15, 2022. Posted in Earnings Releases And Operating Results.

AIM CEO Thomas K. Equels AIM CEO Thomas K. Equels– On track to commence Phase 2 study for lead program evaluating Ampligen® (rintatolimod) for the treatment of pancreatic cancer in Q3 2022 – Well-positioned to achieve multiple near-term clinical and regulatory value-driving milestones – Capital position expected to fund company through end of 2023 OCALA, Fla., Aug. 15, 2022 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE: American AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, the disease caused by the SARS-CoV-2 virus, today reported its financial results for the second quarter 2022 and provided a business update. “As the second quarter results demonstrate, we believe we...

Team, Inc. Reports Second Quarter 2022 Results

Written by Customer Service on August 15, 2022. Posted in Earnings Releases And Operating Results.

Consolidated revenue increased 5% over 2Q 2021 Announced strategic sale of Quest Integrity Business to Baker Hughes SUGAR LAND, Texas, Aug. 15, 2022 (GLOBE NEWSWIRE) — Team, Inc. (NYSE: TISI) (“TEAM” or the “Company”), a global leading provider of integrated, digitally-enabled asset performance assurance and optimization solutions, today reported its financial results for the second quarter ended June 30, 2022. Second Quarter 2022 Financial and Operational Results:Second quarter 2022 revenues were $251.3 million, an increase of 5.2% over the prior year quarter Gross margin was $70.0 million (27.8% of revenues), up $7.2 million from $62.8 million (26.3% of revenues) in Q2 2021 GAAP net loss was $21.6 million Consolidated Adjusted EBITDA was $14.3 million, up 57% as compared to $9.1 million in the 2021 period; and Announced strategic...

Impel Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Corporate Update

Written by Customer Service on August 15, 2022. Posted in Earnings Releases And Operating Results.

Trudhesa® TRx’s Grew 48% in Q2 2022 to Over 13K: Net Product Revenue Increased 59% Over Q1 2022 to $2.8 Million Sales Force Expanded by 50% to Capitalize on Prescription Momentum and Market Opportunity Company Reiterated Prescription Guidance Range of 70-85K TRx’s for 2022 Initiated Proof-of-Concept Study for INP105 in Autism Spectrum Disorder Impel to Host Investor Conference Call Today at 8:30 A.M. ET SEATTLE, Aug. 15, 2022 (GLOBE NEWSWIRE) — Impel Pharmaceuticals (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, today reported financial results for the second quarter ended June 30, 2022 and provided a corporate update. “We continue to see robust growth and momentum with Trudhesa®, with a forty-eight percent increase...

Xcel Brands, Inc. Announces Second Quarter 2022 Results

Written by Customer Service on August 15, 2022. Posted in Earnings Releases And Operating Results.

Second quarter GAAP net income of $9.5 million, or $0.48 per diluted share Second quarter non-GAAP net loss of $3.6 million, or $(0.18) per diluted share During the quarter, Xcel sold a majority interest in its Isaac Mizrahi brand and entered into a joint venture and management agreement with the buyer, recognizing a gain of $20.6 million Approximately 65% of cash proceeds from the Isaac Mizrahi transaction used to pay off all outstanding debt, eliminating approximately $4.5 million of annual debt service expense Strengthened balance sheet with $10.9 million of cash and cash equivalents, no debt, and $16.7 million of working capital at June 30, 2022NEW YORK, Aug. 15, 2022 (GLOBE NEWSWIRE) — Xcel Brands, Inc. (NASDAQ: XELB) (“Xcel” or the “Company”), a media and consumer products company with significant expertise in livestream...

Dynacor Reports a Quarterly Net Income of $2.6 Million in Q2-2022 (US$0.07 or CA$0.09 per Share) and Sales of $53.9 Million

Written by Customer Service on August 15, 2022. Posted in Earnings Releases And Operating Results.

Dynacor is a dividend paying industrial gold ore processor headquartered in Montreal, Canada. The Corporation is engaged in the production of gold through the processing of ore purchased from the ASM (artisanal and small-scale mining) industry. Dynacor currently operates in Peru, where its management and processing teams have decades of experience working with ASM miners. It also owns a gold exploration property (Tumipampa) in the department of Apurimac.The Corporation also intends to expand its processing operations in other jurisdictions.Dynacor produces environmentally and socially responsible gold through its PX IMPACT® gold program. A growing number of supporting firms from the luxury fine jewelry, watchmaking and investment sectors pay a small premium to our client and strategic partner for this PX IMPACT® gold....

Month: August 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals